Cargando…
Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model
A recent study of multidrug resistance (MDR) 1 gene transfected osteosarcoma cells found a cause-effect relationship between increased expression of P-glycoprotein (P-gp) and a low aggressive phenotype. However, several experimental and clinical studies have observed contradictory findings in that P...
Autores principales: | Takeshita, H, Kusuzaki, K, Murata, H, Suginoshita, T, Hirata, M, Hashiguchi, S, Ashihara, T, Gebhardt, M C, Mankin, H J, Hirasawa, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374486/ https://www.ncbi.nlm.nih.gov/pubmed/10755409 http://dx.doi.org/10.1054/bjoc.1999.1099 |
Ejemplares similares
-
Photodynamic Inactivation with Acridine Orange on a Multidrug‐resistant Mouse Osteosarcoma Cell Line
por: Kusuzaki, Katsuyuki, et al.
Publicado: (2000) -
Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
por: Yang, X, et al.
Publicado: (2014) -
In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance
por: Mistry, P, et al.
Publicado: (1999) -
Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma
por: Horie, N, et al.
Publicado: (2007) -
Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts.
por: Takamiya, Y., et al.
Publicado: (1997)